Encompass Health Corporation (EHC)

Encompass Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	566.2	455.7	352	271	412.2
Depreciation & Amortization	327.9	299.6	273.9	243.6	219.6
Other Amortization	9.6	9.7	9.5	9.7	7.8
Loss (Gain) on Equity Investments	-0.2	1	-1.6	1.1	-0.8
Stock-Based Compensation	56.5	48.3	50.6	29.2	29.1
Other Operating Activities	212.7	169.7	132.1	129.3	6.7
Change in Accounts Receivable	-15.2	3	-22.4	-16.9	-39.5
Change in Accounts Payable	-22.6	3	11.8	2.3	15.6
Change in Other Net Operating Assets	42.1	15.9	60.9	-15.8	-86
Operating Cash Flow	1,176	1,003	850.8	705.8	715.8
Operating Cash Flow Growth	17.23%	17.87%	20.54%	-1.40%	1.57%
Capital Expenditures	-736.4	-642.5	-583.1	-584.1	-545.7
Other Investing Activities	-28.2	-10.8	-19.7	-42.9	-120.6
Investing Cash Flow	-764.6	-653.3	-602.8	-627	-666.3
Long-Term Debt Issued	220	95	80	251.8	300
Long-Term Debt Repaid	-249	-337	-163.3	-750	-359.1
Net Debt Issued (Repaid)	-29	-242	-83.3	-498.2	-59.1
Repurchase of Common Stock	-178	-43.2	-8.2	-7.3	-14.6
Common Dividends Paid	-71.1	-62.8	-60.4	-99	-112.2
Other Financing Activities	-153.1	17.4	-45.3	458.8	-54.2
Financing Cash Flow	-431.2	-330.6	-197.2	-145.7	-240.1
Net Cash Flow	-20.2	18.9	50.8	-66.9	-190.6
Free Cash Flow	439.2	360.3	267.7	121.7	170.1
Free Cash Flow Growth	21.90%	34.59%	119.97%	-28.45%	-45.46%
Free Cash Flow Margin	7.40%	6.71%	5.58%	2.80%	4.24%
Free Cash Flow Per Share	4.30	3.52	2.64	1.21	1.70
Cash Interest Paid	-	146.8	147.7	178.4	-
Cash Income Tax Paid	-	163.8	106.6	50.2	129.6
Levered Free Cash Flow	296.79	215.84	123.69	-3.34	-73.86
Unlevered Free Cash Flow	364.19	292.01	203.88	96.78	21.03
Change in Working Capital	4.3	21.9	50.3	-30.4	-109.9

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q